Merus Nv share price logo

Merus Nv Share Price

NASDAQ: MRUS

Mid Cap

$94.89

+0.47

(+0.50%)

as on

Merus Nv Stock Performance

as on October 25, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $94.4
    $95.06
    downward going graph

    0.52%

    Downside

    0.18%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $33.19
    $95.06
    downward going graph

    65.02%

    Downside

    0.18%

    Upside

    downward going graph

Merus Nv share price movements today

Previous Close
$94.42
Open
$94.54
Volume
3.1M
Day's Low - High
$94.4 - $95.06
52 Week Low - High
$33.19 - $95.06

Merus Nv Historical Returns

1 Month Return
+ 39.32 %
3 Month Return
+ 41.99 %
1 Year Return
+ 78.82 %
3 Year Return
+ 301.01 %
5 Year Return
+ 626.49 %

Merus Nv Stock Fundamentals & Key Indicators

Check Merus Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.2B

EPS (TTM)

-5.6038

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-344.5M

Revenue (TTM)

56.2M

Profit Margin

0.00%

Return On Equity TTM

-48.54%

Merus Nv vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Merus Nv with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$7.2B626.49%NA0.00%
BUY$60.9B251.51%-505.15-12.96%
NA$35.7BNANA-3.89%
BUY$109.3B99.16%30.0431.86%
BUY$62.0B-0.32%14.5131.37%

Stock Returns calculator for Merus Nv Stock including INR - Dollar returns

The Merus Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Merus Nv investment value today

Current value as on today

₹1,83,397

Returns

₹83,397

(+83.4%)

Returns from Merus Nv Stock

₹78,835 (+78.84%)

Dollar Returns*

₹4,562 (+4.56%)

Analyst Recommendation on Merus Nv Stock

Based on 20 analysts

BUY

95.00%

Buy

5.00%

Hold

0.00%

Sell

Based on 20 analysts, 95% of analysts recommend a 'BUY' rating for Merus Nv. Average target price of $97

Merus Nv Share Price Target

Get share price movements and forecasts by analysts on Merus Nv.

What analysts predicted

2.18%UPSIDE

Target Price

$97

Current Price

$94.89

Analyzed by

20 Analysts

Target

$97.00

Merus Nv target price $97, a slight upside of 2.18% compared to current price of $94.89. According to 20 analysts rating.

Merus Nv Stock’s Investor Sentiment and Interest

Search interest for Merus Nv Stock has increased by 356% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:356% versus previous 30 day period

Merus Nv Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
12
9
10
8
7
6
10
9
24
7
Gross Profit
-19
-16
7
5
-28
-39
4
9
-49
-72
Operating Income
-33
-31
-36
-43
-43
-60
-64
-88
-70
-93
EBITDA
-33
-30
-35
-42
-42
-59
-64
-88
-69
-93
Interest Expense
1
-
-
12
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-37
-27
-20
-53
-30
-44
-87
-29
-87
-132
Income Tax Expense
0
1
1
0
1
2
2
1
1
1
Net Income
-36
-29
-21
-54
-31
-46
-89
-30
-89
-134
Net Profit Margin
-294.40%
-305.78%
-208.57%
-672.93%
-436.76%
-682.52%
-848.67%
-338.33%
-364.22%
-1792.23%

Merus Nv Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
2
21
33
27
24
43
38
39
34
Gross Profit
-14
-15
-12
-14
-21
-32
-43
28
29
12
Operating Income
-23
-27
-35
-39
-52
-62
-79
-149
-141
-262
EBITDA
-18
-26
-33
-39
-49
-60
-77
-148
-139
-260
Interest Expense
0
20
13
0
6
18
0
2
14
30
Depreciation
-
-
0
0
1
1
1
1
2
2
Income Before Tax
-23
-47
-64
-24
-48
-69
-58
-121
-137
-199
Income Tax Expense
0
0
0
0
0
0
0
0
2
7
Net Income
-23
-47
-64
-24
-49
-70
-58
-122
-140
-207
Net Profit Margin
-1220.79%
-1889.92%
-295.57%
-73.77%
-177.15%
-285.59%
-136.06%
-315.48%
-352.56%
-595.93%

Merus Nv Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-32
-23
-60
-34
-50
-99
-30
-96
-158
Operating Cash Flow
-41
-27
-34
-44
5
-80
-66
-96
-69
Investing Cash Flow
-24
8
-1
-12
3
-133
-
-8
-7
Financing Cash Flow
65
162
-1
30
442
10
8
6
333
Change in Cash
-1
140
-36
-26
451
-195
-139
-96
245

Merus Nv Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-49
-87
-27
-55
-85
-66
-131
-154
-215
Operating Cash Flow
-27
-44
-46
-63
-79
-59
-149
-142
-185
Investing Cash Flow
0
-49
-22
24
-1
-146
2
-27
-220
Financing Cash Flow
52
223
59
74
39
281
58
230
494
Change in Cash
25
111
-6
33
-34
78
-93
56
89

Global Institutional Holdings in Merus Nv

Funds
Holdings
FMR Inc
9.9%
Paradigm Biocapital Advisors LP
5.66%
RTW INVESTMENTS, LLC
5.29%
Wellington Management Company LLP
4.93%
COMMODORE CAPITAL LP
4.66%

Merus Nv News & Key Events

  • img

    Today's Timeline - 29 September

    Mon, 05:02 PM

    -

    Genmab expects to finalize the Merus acquisition in Q1 2026, enhancing its drug pipeline.

    Mon, 07:16 PM

    -

    Citi downgraded Merus to Neutral after Genmab's acquisition announcement, with a price target of $97.

    Mon, 07:45 PM

    -

    Genmab's acquisition of Merus valued at $97 per share, a 41% premium over previous closing price.

  • img

    Today's Timeline - 29 September

    Mon, 09:18 PM

    -

    Merus shares surged 36% after Genmab agreed to acquire the company for $8 billion, or $97 per share.

Insights on Merus Nv

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MRUS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MRUS stock has moved up by 39.3%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MRUS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -30.92M → -134.32M (in $), with an average decrease of 119.5% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 24.48M → 7.49M (in $), with an average decrease of 69.4% per quarter

About Merus Nv

merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. our most advanced development programs use the biclonics® format. biclonics® are capable of simultaneously attacking tumors in multiple ways. for example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
OrganisationMerus Nv
HeadquartersUppsalalaan 17, Utrecht, Netherlands, 3584 CT
IndustryHealth Technology
CEODr. Sven Ante Lundberg M.D.
E-voting on sharesClick here to vote

Key Management of Merus Nv

Name

Title

Dr. Sven Ante Lundberg M.D.

CEO, President & Executive Director

Mr. Peter B. Silverman J.D.

EVP, Company Secretary, COO, General Counsel, Chief Intellectual Property Officer & Head of US Legal

Dr. Fabian Zohren M.D., Ph.D.

Chief Medical Officer

Mr. Cornelis Adriaan de Kruif Ph.D.

CTO & Executive VP

Ms. Kathleen Farren

Director of IR & Corporate Communications Officer

Mr. Gregory D. Perry

Chief Financial Officer

Dr. Hennie Hoogenboom

Co-Founder and Scientific Advisor

Mr. Harry Shuman

Chief Accounting Officer

Dr. Cecilia Anna Wilhelmina Geuijen Ph.D.

Chief Scientific Officer & Senior VP

Ms. Sherri Spear

Senior Vice President of Investor Relations & Strategic Communications

FAQs

What is Merus Nv share price today?

Merus Nv share price today is $94.89 as on at the close of the market. Merus Nv share today touched a day high of $95.06 and a low of $94.4.

What is the 52 week high and 52 week low for Merus Nv share?

Merus Nv share touched a 52 week high of $95.06 on and a 52 week low of $33.19 on . Merus Nv stock price today i.e. is closed at $94.89,which is 0.18% down from its 52 week high and 185.90% up from its 52 week low.

What is Merus Nv's market capitalisation today?

Merus Nv market capitalisation is $0.01T as on .

How to invest in Merus Nv Stock (MRUS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Merus Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Merus Nv Shares that will get you 0.0158 shares as per Merus Nv share price of $94.89 per share as on October 25, 2025 at 1:29 am IST.

What is the minimum amount required to buy Merus Nv Stock (MRUS) from India?

Indian investors can start investing in Merus Nv (MRUS) shares with as little as ₹87.759 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.59 in Merus Nv stock (as per the Rupee-Dollar exchange rate as on ). Based on Merus Nv share’s latest price of $94.89 as on October 25, 2025 at 1:29 am IST, you will get 0.1054 shares of Merus Nv. Learn more about fractional shares .

What are the returns that Merus Nv has given to Indian investors in the last 5 years?

Merus Nv stock has given 626.49% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?